Certified-PEP, a U.S.-based supplier of peptides and compounds for laboratory research, has published its 2026 Research Peptide Supplier Comparison, a 100-point evaluation of 10 suppliers conducted in October 2026. The announcement matters less as a ranking exercise than as a prompt for qualified research customers to examine how much verifiable documentation suppliers actually disclose, because the report found meaningful differences in the availability of manufacturing information, independent testing records, public customer reviews and purchasing options.
The comparison examined American Peptides, BioLongevity Labs, Certified-PEP, Glacier Aminos, Hydro Research, Instant Peptides, Ion Peptide, Mile High Compounds, Modern Peptides and Phoenix Pharmaceuticals. Scoring covered testing and COA transparency, manufacturing disclosures, customer reviews, pricing, checkout functionality, shipping information and payment options. One area of particular interest was Certificates of Analysis and the extent to which suppliers make analytical testing information accessible, including whether the laboratories performing testing are identified, whether documentation corresponds to specific product batches and whether manufacturing-origin information is available. The scoring methodology and individual supplier results are set out in the full report.
The implications extend to how research buyers assess quality claims. A Certificate of Analysis documents analytical testing performed on a particular material or batch, potentially covering product identity, purity, analytical methods and other quality-related characteristics. Batch-specific documentation lets buyers review analytical information tied to the materials they receive rather than relying on general product descriptions or stated purity levels. The report encourages questions about which laboratory performed testing, what methods were used and whether results can be independently reviewed. It also distinguishes a stated purity percentage from more comprehensive analytical documentation, noting that purity testing alone does not necessarily establish a compound's identity or address every characteristic relevant to laboratory research.
Certified-PEP describes its own practices as emphasizing U.S. manufacturing, independent batch testing and accessible documentation. All product batches are tested by Vanguard Laboratory, with Certificates of Analysis made available for corresponding products, and QR codes on every vial allow customers to access available batch-specific documentation through Vanguard Laboratory's reporting system. Those practices are presented as an example of the manufacturing origin, analytical testing and traceability information the comparison asks buyers to look for.
Readers should weigh the source. Certified-PEP conducted the study and was itself one of the suppliers evaluated, so the findings represent a company-published comparison rather than independent third-party research. The published methodology and supporting information allow readers to examine the criteria and assess the findings themselves. The report includes a side-by-side comparison of the 10 suppliers, individual scoring results, analytical documentation examples and a checklist of questions for evaluating research compound suppliers. More information on Certified-PEP and its approach is available through the company. The report also states that a COA documents the results of specified analytical tests and does not, by itself, establish that a research compound is safe or effective for human use, and that Certified-PEP products are intended solely for in-vitro laboratory research.
